Artificial Intelligence in Drug Delivery System Design: From Predictive Modeling to Inverse Formulation Design

Authors

  • Balaji Nagarajan Principal Scientist, Apicore LLC,148 Princeton Hightstown Road, New Jersey, USA.
  • Mohammed Thariq Post Graduate, Department of Psychiatry, Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry, India.

Abstract

AI is revolutionising medication delivery research by enabling data-driven prediction, multidimensional formulation optimisation and rational design of delivery devices with increased therapeutic performance. Traditional drug delivery development is heavily dependent on iterative experimental approaches, empirical manipulation of formulations and step-wise optimisation of single formulation variables which are resource intensive and potentially inadequate to capture complex non-linear interactions between drugs, excipients, physicochemical characteristics, biological barriers and process parameters. Machine learning, deep learning, artificial neural networks and AI-based generative computational techniques offer possibilities to model these multidimensional interactions and to speed up the finding of formulations with defined performance features. Predictive modelling can be used to predict drug release kinetics, physico-chemical stability, pharmacokinetic behaviour, drug-excipient compatibility and carrier related properties to support early stage formulation decisions. AI-assisted optimisation enables systematic combination of formulation and process parameters to identify parameter combinations that result in good drug loading capacity, particle properties, encapsulation efficiency, stability and controlled or targeted release. More recently, a new paradigm was developed called inverse design approaches where the desired therapeutic/material features are first described and mathematical models then propose potential formulations that can achieve the predefined characteristics. Coupling generative AI with inverse design could further boost this capacity to build novel delivery structures outside the empirically investigated formulation space. However, there remain several challenges to be addressed, including data heterogeneity, limited datasets, model interpretability, external validation, reproducibility, regulatory approval, and the translation of computational predictions to clinically viable formulations. This review critically discusses the evolving role of AI in drug delivery with focus on forecasting, formulation optimisation and emerging inverse design strategies as well as translational barriers and future opportunities to develop more efficient, personalised and rationally engineered systems for drug delivery.           

Keywords:

Artificial Intelligence (AI), Drug Delivery Systems, Machine Learning, Formulation Optimization, Predictive Modeling, Inverse Design

DOI

https://doi.org/10.37022/wjcmpr.v8i3.469

References

1. Ros H, Chan N, Cook MT, Shorthouse D. Artificial intelligence and machine learning guided optimization in drug delivery. Advanced Drug Delivery Reviews. 2026; 232:115781. doi: 10.1016/j.addr.2026.115781.

2. Shen C, Zhang M, Lu M, et al. Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives. ActaPharmaceuticaSinica B. 2026;16(2):665–685. doi: 10.1016/j.apsb.2025.12.011.

3. Advances in artificial intelligence for drug delivery and development: A comprehensive review. Computers in Biology and Medicine. 2024; 178:108702. doi: 10.1016/j.compbiomed.2024.108702.

4. Blas-Gómez S, Alonso-Moreno C, Ocaña A, Bravo I. From trial-and-error to inverse design: how AI is redefining drug delivery systems. Drug Discovery Today. 2026;31(4):104725. doi: 10.1016/j.drudis.2026.104725.

5. Generative AI for drug discovery and protein design: The next frontier in AI-driven molecular science. Medical Innovations and Discoveries. 2025. doi: 10.1016/j.medidd.2025.100213.

6. Ros H, Chan N, Cook MT, Shorthouse D. Artificial intelligence and machine learning guided optimization in drug delivery. Advanced Drug Delivery Reviews. 2026; 232:115781. doi: 10.1016/j.addr.2026.115781.

7. Artificial intelligence for drug delivery: Yesterday, today and tomorrow. ActaPharmaceuticaSinica B. 2026;16(4):2068–2092. doi: 10.1016/j.apsb.2025.09.022.

8. Artificial Intelligence and Machine Learning Implemented Drug Delivery Systems: A Paradigm Shift in the Pharmaceutical Industry. Journal of Bio-X Research. 2024;7. doi:10.34133/jbioxresearch.0016.

9. Shen C, Zhang M, Lu M, et al. Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives. ActaPharmaceuticaSinica B. 2026;16(2):665–685. doi: 10.1016/j.apsb.2025.12.011.

10. High-throughput, AI-assisted design and optimization of lipid nanoparticles for drug delivery. Journal of Controlled Release. 2026; 391:114573. doi: 10.1016/j.jconrel.2025.114573.

11. Artificial intelligence and machine learning in nanoparticle drug delivery systems. Nature Reviews Bioengineering. 2026.

12. Nithyanantham D, Nair A, Nayak UY. Leveraging Artificial Intelligence for Advancements in Liquid Dosage Formulations in the Pharmaceutical Industry. Therapeutic Innovation & Regulatory Science. 2025; 59:1004–1031. doi:10.1007/s43441-025-00823-w.

13. Blas-Gómez S, Alonso-Moreno C, Ocaña A, Bravo I. From trial-and-error to inverse design: how AI is redefining drug delivery systems. Drug Discovery Today. 2026;31(4):104725. doi: 10.1016/j.drudis.2026.104725.

14. Rahman T, Tahmid A, Arman SE, et al. Leveraging generative neural networks for accurate, diverse, and robust nanoparticle design. Nanoscale Advances. 2025; 7:634–642. doi:10.1039/D4NA00859F.

15. In silico formulation optimization and particle engineering of pharmaceutical products using a generative artificial intelligence structure synthesis method. Nature Communications. 2024; 15:9622.

Published

2026-11-18
Statistics
Abstract Display: 0
PDF Downloads: 0
Dimension Badge

How to Cite

1.
Artificial Intelligence in Drug Delivery System Design: From Predictive Modeling to Inverse Formulation Design. World Journal of Current Med and Pharm Research [Internet]. 2026 Nov. 18 [cited 2026 Nov. 19];8(3):257-61. Available from: https://www.wjcmpr.org/index.php/journal/article/view/469

Issue

Section

Review Articles

How to Cite

1.
Artificial Intelligence in Drug Delivery System Design: From Predictive Modeling to Inverse Formulation Design. World Journal of Current Med and Pharm Research [Internet]. 2026 Nov. 18 [cited 2026 Nov. 19];8(3):257-61. Available from: https://www.wjcmpr.org/index.php/journal/article/view/469